Trastuzumab duocarmazine in locally advanced and metastatic solid tumours and HER2-expressing breast cancer: a phase 1 dose-escalation and dose-expansion study

Udai Banerji, Philippe Aftimos, Fiona Thistlethwaite et al.|The Lancet Oncology|2019

Cited by 564